Monthly Prescribing Reference

FDA Expands Approval of ACAM2000 to Include Prevention of Mpox Disease

The vaccine is administered percutaneously using a bifurcated needle that is dipped into the vaccine solution; the skin is then pricked several times in the upper arm. The Food and Drug Administration ...
Oklahoma's News

Emergent BioSolutions’ ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication; Public Health Mpox Outbreak Continues Across ...

GAITHERSBURG, Md., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics ...
Yahoo

Emergent to donate 50,000 vaccine doses to address mpox outbreak in Africa

Add Yahoo as a preferred source to see more of our stories on Google. Children at risk as mpox variant hits Congo displacement camps (Reuters) -Emergent BioSolutions said on Monday it would donate ...
Morningstar

Emergent BioSolutions Receives New Contract Modification for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government, Further Demonstrating Importance ...

ACAM2000 ® is also licensed for smallpox in Canada, Australia and Singapore and is currently stockpiled both in the U.S. and internationally. This contract modification is under Emergent’s existing 10 ...
Seeking Alpha

Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts

GAITHERSBURG, Md., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has secured approximately $400 million in orders in 2024 and 2025 associated with its ...
Seeking Alpha

Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa

GAITHERSBURG, Md., Aug. 19, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions (EBS) today announced it is proactively working with the World Health Organization (WHO) and the U.S. government to partner ...